Funded Tech Companies
Syntis Bio
Syntis Bio is a biopharmaceutical venture, based in Boston. Financial backing came from W. R. Berkley, Safar & Partners and Cerberus Capital Management.
Company Overview
Company Name
Syntis Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
135 Morrissey Boulevard 101A
Boston, MA 02125
USA
Boston, MA 02125
USA
Phone
Website
Email Address
Company Background Information
Overview
Our mission is to develop oral therapies that harness the small intestine's unique biology to provide more accessible, effective and sustainable solutions across the healthcare spectrum, from rare genetic disorders to the world's most prevalent conditions. Syntis is revolutionizing oral therapy for obesity, diabetes and rare diseases by unlocking the full therapeutic potential of the small intestine.
Last Transaction
7/1/2025
Financing History
Date
Type
Amount
Management Team
Company Investors
- W. R. Berkley
- Safar & Partners
- Cerberus Capital Management
- Apollo Crypto
- Woori Venture Partners
- Bold Capital Partners
- Colorcon Ventures
- Portal Innovations
Browse more funded tech companies:
Syntimmune | Syntonix Pharmaceuticals
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs